112 results
Page 2 of 6
8-K
EX-99.1
wqin0
9 Aug 23
Harpoon Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
4:25pm
424B3
uk80ygq
30 May 23
Prospectus supplement
4:48pm
424B5
djy tjyq4
16 May 23
Prospectus supplement for primary offering
6:09am
8-K
EX-99.1
8czcxy 3lx5g
11 May 23
Harpoon Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
9:07pm
PRE 14A
wfvc v70jr
14 Apr 23
Preliminary proxy
4:54pm
8-K
EX-99.1
f27f32azkv72 b0ss
12 Dec 22
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma
4:03pm
8-K
EX-99.1
2olql4abevv
14 Nov 22
Harpoon Therapeutics Updates Strategic Priorities and Reports Third Quarter 2022 Financial Results
5:17pm
8-K
EX-10.1
oaqy4wjfn8wtu3zh9zo
28 Jun 22
Departure of Directors or Certain Officers
4:02pm